TENX
TENX
NASDAQ · Biotechnology

Tenax Therapeutics Inc

$14.90
-0.07 (-0.47%)
Financial Highlights (FY 2025)
Revenue
19.99M
Net Income
4.98M
Gross Margin
65.9%
Profit Margin
24.9%
Rev Growth
+24.3%
D/E Ratio
0.81
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 65.9% 65.9% 65.9%
Operating Margin 24.3% 26.6% 23.8%
Profit Margin 24.9% 24.0% 23.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.99M 20.76M 15.61M
Gross Profit 13.18M 13.68M 10.29M
Operating Income 4.86M 5.52M 3.71M
Net Income 4.98M 4.98M 3.68M
Gross Margin 65.9% 65.9% 65.9%
Operating Margin 24.3% 26.6% 23.8%
Profit Margin 24.9% 24.0% 23.6%
Rev Growth +24.3% +21.0% +20.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 39.93M 39.83M 42.30M
Total Equity 49.49M 55.25M 49.51M
D/E Ratio 0.81 0.72 0.85
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 7.23M 8.32M 5.37M
Free Cash Flow 5.95M 3.82M 3.47M